Kenya’s Collaborative Surveillance of Bundibugyo Virus Disease: An Assessment

 

Introduction

On the night of 5 October 2026, a Kenyan citizen who had lived in the Democratic Republic of Congo for seven years died in a Nairobi hospital of Bundibugyo virus disease. He had fallen ill approximately a month earlier while in the DRC, was treated at several health facilities there, then travelled by road from Beni through Uganda, spent a night in Kampala, and flew to Nairobi on 3 October aboard Jambojet flight 8523. He underwent routine public health screening at the port health and immigration desks at Jomo Kenyatta International Airport. He was not detected. He was taken directly from the airport to a Nairobi hospital by a relative and a friend, where he was isolated after presenting with fever, chills, intense fatigue, muscle pain, painful swallowing, and bleeding under the skin at injection sites. Samples tested positive for Bundibugyo virus at both the National Virology Reference Laboratory and the KEMRI laboratory. He died before the diagnosis was confirmed.

Kenya had been on heightened alert since May 2026, when the DRC outbreak was declared a Public Health Emergency of Continental Security. By 6 October, the government had screened 652,584 travellers at 15 points of entry, tested 267 samples in five laboratories, and trained 4,971 health workers on Ebola prevention and management. The World Health Organization’s July 2026 situation report showed Kenya’s Ebola preparedness score had improved from 66 per cent to 82 per cent. The architecture of preparedness, by the government’s own metrics, was in place.

And yet a symptomatic patient passed through JKIA undetected. This is the event that this analysis examines.

The Bundibugyo strain of Ebola virus is not the Zaire strain for which the Ervebo vaccine and monoclonal antibody treatments have been licensed. There are currently no approved vaccines or specific treatments for Bundibugyo virus disease. The Africa CDC has stated that response strategies must rely entirely on comprehensive public health measures: rapid case detection, isolation, contact tracing, infection prevention and control, safe burials, and community engagement. When medical countermeasures do not exist, surveillance is not one component of the response. It is the entire response. If surveillance fails at the point of entry, the case enters the community. If it fails at the isolation facility, the case exposes healthcare workers. If it fails at the laboratory, the case remains unconfirmed while contacts multiply.

This essay assesses whether Kenya can effectively perform collaborative surveillance for Bundibugyo virus disease. Collaborative surveillance , the first pillar of the WHO’s Health Emergency Preparedness and Response framework, encompasses the systems required to detect a suspected case at the earliest possible point: functional alert systems at points of entry, rapid response teams capable of immediate investigation, isolation facilities that can safely contain a patient, reference laboratories that can confirm a diagnosis, contact tracing systems that can identify and monitor every exposure, and laboratory turnaround times measured in hours rather than days.

The assessment proceeds in three stages. It first establishes the operational requirements for each component of collaborative surveillance, drawing on WHO and CDC benchmarks, including the 7-1-7 model that sets performance targets of seven days to detect an outbreak, one day to notify public health authorities, and seven days to complete early response actions. It then audits Kenya’s existing resources against those requirements, using verified data from government reporting, WHO assessments, and independent frontline accounts. It concludes with a judgment on whether the system, as currently constituted and deployed, is capable of detecting an imported Bundibugyo case before that case generates secondary transmission.

The evidence assembled in this analysis leads to a single conclusion: Kenya cannot effectively surveil Bundibugyo virus disease. The system has been tested once. It did not perform. This essay examines why.

Collaborative Surveillance: Detection Before Transmission — An Operational Resource Audit

Core requirement: Rapid identification of suspected cases at all levels — community, health facility, and points of entry.

Collaborative surveillance is the pillar upon which every subsequent containment action depends. In Ebola, the virus does not announce itself. It presents initially as a non-specific febrile illness with fever, headache, muscle pain, fatigue that is indistinguishable from malaria, typhoid, or influenza in their early stages. The window between symptom onset and laboratory confirmation is the window in which transmission is either interrupted or amplified.

This section audits Kenya’s collaborative surveillance architecture against the operational requirements established by WHO and CDC benchmarks. It proceeds by identifying the specific sites, personnel, and equipment required, and estimating the resources needed for each of the six components of collaborative surveillance: the functional alert system, rapid response teams, isolation centres, reference laboratories, contact tracing, and laboratory turnaround time.

1. Functional Alert System: Sites, Personnel, and Equipment

Requirements. A functional alert system is not a passive infrastructure. It requires trained personnel at designated sites, operating equipment capable of detecting febrile illness, and a clear protocol for escalating a suspected case to the rapid response team. The WHO’s operational guidance for Ebola preparedness in at-risk countries specifies that this alert system must operate at major land border crossings with already affected countries, capital cities including airports and seaports, and health-care facilities, especially major hospitals.

Kenya maintains 35 official Points of Entry and Exit (POEs) distributed across three border categories: 17 land border crossing points, nine air entry and exit points, and nine sea entry and exit points. The nine airports are Jomo Kenyatta International Airport (JKIA), Mombasa International Airport, Wilson Airport, Kisumu International Airport, Eldoret International Airport, Wajir Airport, Lokichogio Airport, Malindi Airport, and Isiolo Airport. The 12 active land border controls are Lungalunga, Taveta, Loitoktok, Namanga, Isebania, Muhuru Bay, Busia, Malaba, Lwakhakha, Suam, Nadapal, and Moyale. The eight seaports are Kilindini, Old Port, Lamu, Vanga, Shimoni, Malindi, Mbita, and Kisumu Pier.

Of these, the land crossings with Uganda, Busia, Malaba, Lwakhakha, and Suam, are the highest priority for BVD surveillance, given that the DRC outbreak has already spread through Uganda. Kenya is the primary transport and trade corridor for several landlocked neighbours, including Uganda, DRC, Rwanda, Burundi, South Sudan, and Ethiopia, with high volumes of traders, truck drivers, migrant workers, and cross-border communities moving daily through Busia, Malaba, Suam, Namanga, and JKIA.

The WHO’s operational checklist specifies that each designated point of entry must have 24/7 staffing with trained teams capable of screening, assessment, and isolation procedures. The equipment standard includes nine full sets of personal protective equipment (PPE) at each point of entry, covering 24 hours a day, seven days a week.

Estimation. For the 35 designated points of entry, a minimum of three trained public health officers per site per 24-hour cycle would be required to maintain round-the-clock screening, consistent with the WHO’s 24/7 staffing standard. This yields a baseline requirement of approximately 105 trained port health officers across all 35 points of entry. Equipment requirements would include a minimum of 315 full PPE sets (nine per point of entry), functional thermal scanners at every site, and holding clinics or designated isolation spaces at the four Uganda border crossings at minimum.

Existing resources. Kenya has intensified screening at 15 points of entry, where more than 652,000 travellers have been screened cumulatively. Health Principal Secretary Mary Muthoni conducted an assessment at JKIA covering passenger screening, thermal scanners, isolation facilities, laboratory readiness, and emergency response coordination. Temporary isolation centres have been identified at Malaba and Kocholia, while Alupe is undergoing renovation. The government has mobilised 1,000 PPE sets donated by WHO and 6,000 provided by the Government of India.

The Association of Public Health Officers has stated that most thermal scanners at points of entry are not operating and that most points of entry lack holding clinics where suspected cases could be temporarily isolated. Some frontline positions are staffed by interns, volunteers, or casual workers rather than qualified public health officers. A traveller arriving from the DRC independently reported being waved through without QR-code verification at JKIA, the same procedure she had undergone in the DRC and Ethiopia. These accounts do not establish that all passengers bypassed screening, but they raise a specific question: if QR-code screening is part of Kenya’s border health framework, was it operational on 3 October 2026?

Alert System Component	Required	Existing	Status
Points of entry with screening	35 designated POEs	15 with intensified screening	Screening concentrated at 15 of 35 sites; 20 POEs without reported intensified measures
Port health officers	105 (3 per POE per 24h)	Not publicly disaggregated by site	Aggregate workforce exists; site-level distribution undocumented
PPE sets	315 (9 per POE)	7,000+ mobilised (1,000 WHO + 6,000 India + government commitment)	Aggregate supply exceeds requirement; last-mile distribution to all 35 POEs not demonstrated
Holding clinics	Required at all designated POEs	Identified at Malaba, Kocholia; Alupe undergoing renovation	Partial: 3 of 35 POEs with reported holding facilities

Assessment. The key finding at this stage is structural: Kenya has the aggregate resources, trained personnel, PPE stocks, and the policy framework for screening, but the operational footprint is concentrated at 15 points of entry rather than the full 35. The WHO benchmark applies to all designated points of entry, not a subset. Whether the remaining 20 POEs have functional screening capacity is not documented in publicly available Ministry of Health reporting. The confirmed case entered through JKIA, one of the 15 screened POEs, and was not detected.

2. Rapid Response Teams: Estimating the Required Number

Requirements. A Rapid Response Team is a multidisciplinary unit trained in case management, specimen collection and transport, contact tracing, decontamination, investigation, social mobilisation, and safe and dignified burials. The WHO’s operational guidance for Ebola preparedness specifies that at least one fully equipped RRT should be established and prepositioned in the capital or in proximity to a high-risk region, and that in priority 1 countries, two teams will be established.

The WHO’s RRT composition includes clinicians, social mobilisers or anthropologists, logisticians, psychosocial support personnel, data managers, and Infection Prevention and Control experts. The CDC’s operational model for Ebola response deployed multidisciplinary teams of four to 10 staff, with the capacity to scale to at least 50 staff members within 30 days during a rapidly escalating outbreak.

Kenya has identified 24 counties as at risk, 14 classified as very high-risk and 10 as high-risk. The very high-risk counties include the Lake Basin counties of Kisumu, Busia, Siaya, Homa Bay, and Migori, classified as such “because of their proximity to borders, major trade routes or high levels of population movement”. Turkana, which borders Uganda, Ethiopia, and South Sudan and hosts refugees from more than 30 nationalities, is also classified as high-risk. Mombasa is designated high-risk due to its port and international airport.

Estimation. Given Kenya’s 24 at-risk counties, 14 of which are very high-risk, a credible RRT deployment would require at least one fully equipped RRT per very high-risk county, with additional teams prepositioned at the national level and in the capital. This yields a minimum requirement of 14 county-level RRTs plus 2 national-level teams, for a total of 16 RRTs. Each RRT, based on the WHO’s multi-disciplinary specification, would comprise a minimum of 8–12 personnel: a team lead (epidemiologist or public health specialist), a case management clinician, an infection prevention and control specialist, a laboratory liaison, a contact tracing coordinator, a risk communication officer, a logistician, and at least two community engagement officers. This yields a total trained RRT workforce of approximately 128–192 personnel dedicated to Ebola response.

Existing resources. Kenya has conducted a Rapid Response Team (RRT) Training of Trainers workshop aimed at strengthening national and sub-national capacity to detect, prevent, and respond to potential outbreaks. The training brought together multidisciplinary experts from national and county governments, health institutions, and partner organisations. The Kenya National Public Health Institute has intensified preparedness through Integrated RRT training programmes in Trans Nzoia County and Turkana County, both classified as high-risk. The US government has committed to training 120 national responders through a National RRT Training of Trainers programme and more than 160 county-level responders in high-risk border counties. National and county rapid response teams are operating in 27 counties. Nairobi County has activated RRTs across all 17 sub-counties, coordinated by the county Emergency Operations Centre.

RRT Component	Required	Existing	Status
County-level RRTs	14 (one per very high-risk county)	RRTs operating in 27 counties	Numerical coverage exceeds requirement; multidisciplinary composition and full equipment status not disaggregated
National RRTs	2	120 national responders trained	Numerical coverage meets requirement
Trained RRT personnel	128–192	120 national + 160 county = 280 trained	Aggregate training numbers exceed requirement
Geographic coverage	14 very high-risk counties	27 counties with active RRTs	Coverage exceeds the at-risk county list

Assessment. The RRT component presents the strongest area of Kenya’s collaborative surveillance architecture. The 280 trained responders across national and county levels exceeds the estimated 128–192 personnel requirement. The caveat is that training numbers do not equal deployment readiness. The WHO benchmark requires fully equipped RRTs, personnel trained, prepositioned, and equipped with PPE, diagnostic supplies, and transport. Whether all 280 trained responders are currently prepositioned with functional equipment in their assigned counties is a question that training completion data alone cannot answer.

3. Isolation Centres: Functional Standards and Bed Capacity

Requirements. A functional Ebola isolation centre is not merely a room with a bed. It is a facility designed around the principle of containment. The WHO’s operational guidance requires that isolation centres be equipped with trained staff, adequate PPE stocks, and the capacity to manage patients for the duration of their infectious period, which may extend for several weeks. Designated beds should be placed in staff areas so that healthcare workers can sleep and rest during extended response operations.

The WHO’s staffing benchmark for Ebola treatment centres is three medical staff per patient. For the DRC outbreak, the WHO planned to create 3,000 beds, requiring the training of 9,000 health workers, a staffing ratio of approximately one clinician to four patients, allowing patient assessment three times daily. Evidence-based guidelines recommend at least one clinician (defined as nurses, clinical officers, or physicians) to four patients.

Estimation. For Kenya, the immediate requirement is a minimum surge capacity sufficient to manage an initial cluster of cases without exhausting the system. A credible minimum for a country of 55 million with 24 at-risk counties would be at least 100 isolation beds distributed across the five designated facilities (Kenyatta National Hospital, Moi Teaching and Referral Hospital, National Police Service Hospital, Port Reitz Hospital, and Nairobi Hospital), with the capacity to rapidly expand to 300 beds if community transmission is detected. At the WHO’s staffing ratio of three medical staff per patient, a 100-bed isolation capacity would require 300 trained clinical staff, and a 300-bed surge capacity would require 900 trained clinical staff.

Existing resources. The government has designated 23 Ebola isolation and treatment centres nationwide, with a combined capacity of 241 beds. The principal facilities include:

·        Kenyatta National Hospital (KNH): Eight-bed infectious diseases unit, supported by 38 healthcare workers specially trained in the management of highly infectious diseases. The unit has managed 58 suspected Ebola cases, all of which tested negative.

·        Nairobi Hospital: 133 beds, including nearly 45 High Dependency Unit and Intensive Care Unit beds.

·        Moi Teaching and Referral Hospital (MTRH): 50 beds (20 isolation beds plus 30 surge beds).

·        Kenya National Police Hospital: 49 beds available for activation as surge isolation capacity.

·        Port Reitz Hospital, Mombasa: Designated as an isolation and treatment facility, with four beds.

Additional facilities are being operationalised in Busia County and other priority areas. A 200-bed National Infectious Diseases Centre is planned to integrate diagnosis, treatment, isolation, surveillance, research, and training under one roof.

Isolation Component	Required	Existing	Status
Total isolation beds	100 minimum; 300 surge	241 beds across 23 facilities	Exceeds minimum requirement; below 300 surge target
KNH capacity	Part of national bed count	8 beds + 38 trained staff	Unit is functional and has operational experience (58 suspected cases managed)
Nairobi Hospital	Part of national bed count	133 beds including 45 HDU/ICU	Largest single facility; significantly exceeds basic isolation standards
MTRH	Part of national bed count	50 beds	Meets facility-level requirement
Trained clinical staff	300 (for 100 beds); 900 (for 300 beds)	4,971 health workers trained nationally	Aggregate training exceeds requirement; disaggregation by facility not publicly documented

Assessment. The isolation centre component presents a mixed picture. The aggregate bed capacity of 241 substantially exceeds the estimated minimum of 100. However, the distribution is uneven: Nairobi Hospital alone accounts for 133 of 241 beds (55%), while KNH, the premier public referral facility, has only eight beds, and Port Reitz in Mombasa has four. The WHO staffing benchmark of three medical staff per patient would require 723 staff for 241 beds. Kenya has trained 4,971 health workers nationally, which exceeds this figure in aggregate. But whether those trained staff are distributed across the 23 designated facilities in proportion to bed capacity is not documented in public reporting.

4. Reference Laboratories: Description and Required Number

Requirements. A national reference laboratory for Ebola testing must operate at Biosafety Level 4 (BSL-4), the highest classification in the international laboratory safety framework. BSL-4 requires negative air pressure systems that prevent any particle from escaping the room, full pressurised suits with independent air supplies, chemical decontamination showers, and waste treatment systems that process everything, including air and water, before it leaves the building. Ebola virus is classified as a Risk Group 4 pathogen, meaning that viral isolation and any protocol involving viable virus should only be carried out in a BSL-4 laboratory.

The WHO’s operational guidance specifies that countries should strengthen national laboratory capability for EVD confirmatory testing, with the facility equipped with trained laboratory staff and supplies to safely perform diagnostic testing. The guidance also requires an efficient and safe system for specimen shipment to the national reference laboratory including sufficient stock of consumables for specimen collection, packaging, and transport.

Estimation. For a country of Kenya’s size and geographic dispersion, a minimum of three BSL-4 or BSL-3+ enhanced reference laboratories is the operational floor, one in Nairobi (serving the capital and central region), one in Kisumu (serving the western border counties and Lake Basin), and one in Mombasa (serving the coast and the port of entry). No expansion beyond three is operationally necessary provided that specimen transport systems from all 24 at-risk counties can deliver samples to these facilities within 4–6 hours, which is the WHO’s operational target for laboratory turnaround time.

Existing resources. Kenya has five designated laboratories supporting Ebola testing, including mobile laboratory capacity. The designated testing centres include the National Public Health Virology Reference Laboratory, KEMRI Nairobi, KEMRI Kisumu, and mobile laboratories deployed to support rapid testing and emergency response in high-risk areas. The Kenya National Public Health Institute hosts four national reference laboratories supporting surveillance and rapid diagnosis of priority diseases, including a Biosafety Level 3 (BSL-3) Central Laboratory. Two US-supported KEMRI laboratories will join the National Virology Reference Laboratory in testing suspected samples. Kenya has more than 40 professionals specifically trained in Ebola testing and diagnosis. More than 800 laboratory professionals will be trained in biosafety, biosecurity, and testing procedures for viral haemorrhagic fevers.

However, it must be noted that Kenya does not currently operate a Biosafety Level 4 (BSL-4) laboratory, the highest level of containment for dangerous pathogens such as Ebola. The country operates BSL-1 to BSL-3 laboratories, including three BSL-3 facilities nationwide. Most Kenyan laboratories operate at BSL-2, and a small number at BSL-3. The National Public Health Virology Reference Laboratory, KEMRI Nairobi, and KEMRI Kisumu are the only three facilities in the country equipped to safely receive, handle, and confirm an Ebola sample.

Laboratory Component	Required	Existing	Status
BSL-4 reference laboratories	3 (Nairobi, Kisumu, Mombasa)	0 BSL-4; 3 facilities equipped for Ebola testing	Geographic coverage partially meets requirement (Nairobi and Kisumu); Mombasa corridor lacks designated BSL-4 capacity
Trained laboratory personnel	Not numerically specified by WHO	40+ Ebola-trained professionals; 800+ to be trained	Aggregate training pipeline exists
Mobile laboratory capacity	Required for rapid deployment	2 mobile laboratories operational	Deployed to high-risk areas including Lwakhakha

Assessment. The reference laboratory component reveals a structural gap that cannot be resolved by training or mobilisation alone. BSL-4 is an infrastructure standard, not a staffing or supply standard. As Dr Ahmed Kalebi has stated: “You cannot upgrade a BSL-2 facility to BSL-4 with a policy decision or an emergency budget line. The building either meets the standard or it does not”. Kenya has three BSL-3 facilities and a functional testing network at BSL-3 level, which is sufficient for diagnostic testing of inactivated samples. But viral isolation and any protocol involving viable virus require BSL-4. The absence of BSL-4 capacity means that Kenya cannot perform the full spectrum of confirmatory laboratory work that a BSL-4 reference laboratory would provide.

5. Contact Tracing: Resource Requirements

Requirements. Contact tracing is the surveillance activity that determines whether an outbreak is contained or amplified. The WHO’s operational guidance for countries with no reported cases specifies that once a case is confirmed, daily medical follow-up of contacts must continue for 21 days after exposure. Contacts must be isolated and receive appropriate care as soon as they show symptoms.

The contact ratio benchmark assumes that each confirmed Ebola patient has interacted with an average of 60 direct or indirect contacts. Africa CDC Director-General Dr Jean Kaseya has stated that for every confirmed Ebola case, health authorities would expect to identify about 60 people who had direct or indirect contact with the infected person. In urban areas, 40 contacts is a more realistic number, while epidemiologists expect a minimum of 20 contacts per infected person.

The WHO and CDC operational guidance specifies that each contact follow-up team should comprise at least two people, with one supervisor for every 5 to 10 contact follow-up teams. A team of at least two members per disinfection team and one team of at least six people per burial team are also required.

Estimation. For Kenya’s current situation, 57 contacts from a single case, the immediate requirement is approximately 29 follow-up teams (two contacts per team) or 15 teams (four contacts per team), supported by 3–6 supervisors. However, if transmission escalates and the 60:1 ratio holds, a cluster of 10 confirmed cases would generate 600 contacts, requiring 150 follow-up teams (four contacts per team) and 15–30 supervisors, totalling 300–600 contact tracing personnel.

Existing resources. Kenya has identified 57 contacts linked to the single confirmed case, with 10 placed under quarantine. The contacts include family members, healthcare workers who attended to the patient, 23 passengers, four crew members, and other individuals linked to the flight. Nairobi County has trained 1,598 Community Health Promoters (CHPs) on early detection, identification, and reporting of suspected Ebola cases, alongside 923 health workers.

Contact Tracing Component	Required	Existing	Status
Follow-up teams (for 57 contacts)	15 teams (4 contacts/team)	Not publicly disaggregated	Contact identification completed; team deployment numbers not documented
Supervisors	3–6 supervisors	Not publicly disaggregated	—
Personnel (for 10-case cluster)	300–600	1,598 CHPs + 923 health workers trained in Nairobi alone	Aggregate trained workforce exceeds requirement
Contact identification ratio	60 contacts per case	57 contacts from 1 case	Identification rate is within expected range

Assessment. The contact tracing component demonstrates adequate aggregate human resources but limited transparency on operational deployment. The 57 contacts identified from a single case aligns with the 40–60 contact ratio benchmark. The 2,521 trained personnel in Nairobi County alone, 923 health workers and 1,598 CHPs, exceeds the 300–600 personnel requirement for a 10-case cluster. However, whether these personnel are organised into functional follow-up teams with supervisors, and whether they are equipped with the tools required for daily monitoring over 21 days, is not documented in public reporting.

6. Laboratory Capacity: Required Turnaround Time

Requirements. Laboratory confirmation is the event that converts a suspected case into a confirmed one, triggers contact tracing, and determines whether isolation can be discontinued. The WHO’s operational guidance for countries without cases specifies that laboratory results should be available within 24 to 48 hours of specimen receipt. If the first test is negative, the patient must be retained in isolation and a second specimen taken within the following 24-hour period.

The operational target, however, is more demanding. In the current Bundibugyo outbreak in the DRC, the WHO reports that decentralised testing using RadiOne diagnostic devices can deliver results in under one hour, and that standard RT-PCR testing in field laboratories now yields results within 4–6 hours, down from 4–5 days when samples were shipped to Kinshasa. GeneXpert machines deployed to Bulape have enabled diagnosis in less than two hours. The WHO’s Western Pacific guidance similarly indicates that RT-PCR results for filoviruses should be expected within 4–6 hours. Category 4 laboratories established locally report results available 4 hours after the sample has arrived.

Existing performance. Kenya’s laboratories have a national turnaround time of six to 12 hours, according to Health Cabinet Secretary Aden Duale. The Ministry of Health has separately stated that designated laboratories are capable of processing and releasing Ebola test results within six to eight hours after receipt of the specimen. The two mobile laboratories at KNPHI have reduced turnaround time from several days to between six and eight hours. A mobile laboratory established at Lwakhakha is designed to deliver Ebola test results within approximately four hours.

Laboratory Turnaround	Required	Existing	Status
National average turnaround	4–6 hours	6–12 hours	Exceeds operational target by 2–6 hours at the national level
Mobile laboratory capability	<1 hour to 4 hours	4 hours at Lwakhakha	Meets operational target at decentralised sites
Point-of-care testing	<1 hour	Not reported as widely deployed	Gap in decentralised testing rollout

Assessment. The laboratory turnaround time component reveals a decentralised capability that exceeds the national average. The national turnaround of 6–12 hours is within the WHO’s 24–48 hour standard but at the upper bound of the 4–6 hour operational target. The mobile laboratory at Lwakhakha, which delivers results in approximately four hours, demonstrates that the operational target is achievable at decentralised sites. The gap is not in capability but in deployment coverage. If mobile laboratory capacity is limited to specific high-risk points of entry, counties without access to a mobile unit will continue to rely on specimen transport to BSL-3 facilities, adding transport time to the already-extended national turnaround.

Summary: Kenya’s Collaborative Surveillance Resources Against Requirements

Component	Required	Existing	Aggregate Status
Alert system	35 POEs with 24/7 screening; 105 officers; 315 PPE sets	15 POEs with intensified screening; 7,000+ PPE sets	Partial: screening concentrated at 15 POEs; PPE supply exceeds aggregate requirement
Rapid response teams	16 RRTs; 128–192 personnel	27 counties with RRTs; 280 trained responders	Exceeds requirement on aggregate numbers
Isolation centres	100 beds minimum; 300 surge; 300–900 staff	241 beds across 23 facilities; 4,971 trained health workers	Exceeds bed minimum; below surge target; staffing exceeds aggregate requirement
Reference laboratories	3 BSL-4/BSL-3+ facilities	0 BSL-4; 3 facilities equipped for Ebola testing; 2 mobile labs	Structural gap: no BSL-4 capacity; geographic coverage partial
Contact tracing	300–600 personnel for 10-case cluster	2,521 trained personnel in Nairobi alone; 57 contacts identified	Exceeds requirement on aggregate trained workforce
Laboratory turnaround	4–6 hours	6–12 hours national; 4 hours at mobile lab	Exceeds target at national level; meets target at decentralised sites

The Structural Finding

The comparison reveals a consistent pattern across the six components of Kenya’s collaborative surveillance architecture. Aggregate resource mobilisation is strong. Kenya has trained more health workers than the minimum requirement, mobilised more PPE than the baseline specification, and designated more isolation beds than the minimum surge capacity. On paper, the resource base is sufficient.

But the comparison also reveals a distribution and deployment gap. Screening is concentrated at 15 points of entry rather than the full 35. Mobile laboratory capacity that meets the 4-hour operational target exists at specific sites (Lwakhakha) but is not reported as widely deployed. The 241 isolation beds are unevenly distributed, with 55% concentrated at a single private facility. And the absence of BSL-4 laboratory capacity is a structural limitation that training and supply mobilisation cannot overcome.

The pattern is consistent across all six components: Kenya’s collaborative surveillance architecture is strongest in functions that depend on human capital, training, recruitment, and deployment of personnel, and weakest in functions that depend on physical infrastructure and geographic coverage, screening equipment at every point of entry, isolation beds in every designated facility, BSL-4 containment, and decentralised laboratory platforms. The system can train people. It struggles to place functional equipment at every border post, isolate every case in a facility equipped to contain it, and confirm every sample within the operational target time.

Conclusion

Kenya cannot effectively surveil Bundibugyo virus disease.

The evidence assembled in this analysis supports that claim on multiple independent grounds.

Kenya operates 35 designated points of entry, but intensified screening was in place at only 15. The confirmed case entered through JKIA, one of the 15 screened sites, and was not detected. The Association of Public Health Officers has stated that most thermal scanners at points of entry are not operating and that most points of entry lack holding clinics for temporary isolation. A traveller arriving from the DRC independently reported being waved through without QR-code verification. The surveillance system, at the point of entry, did not perform.

Kenya’s national laboratory turnaround time is six to twelve hours. The operational target for Ebola containment is four to six hours, with decentralised testing demonstrating results in under one hour. For a disease with no approved vaccine or therapeutic for the Bundibugyo strain, a result that takes half a day means a suspected case remains unisolated for half a day longer than containment permits.

Kenya’s 241 isolation beds are concentrated rather than distributed. The Nairobi Hospital holds 133 of them, 55 per cent. Kenyatta National Hospital, the flagship public referral facility, holds eight. Port Reitz in Mombasa holds four. A country with 24 at-risk counties cannot credibly claim isolation capacity when its premier public hospital can hold eight patients and its coastal port city can hold four.

Kenya does not operate a Biosafety Level 4 laboratory. Viral isolation and any protocol involving viable Ebola virus require BSL-4 containment. Three BSL-3 facilities provide diagnostic testing of inactivated samples, but the structural capacity for full-spectrum laboratory work does not exist.

Kenya’s rapid response teams and contact tracing workforce exceed numerical requirements. This is the system’s genuine strength, 280 trained responders, 2,521 trained personnel in Nairobi County alone. But personnel-intensive functions cannot compensate for infrastructure-intensive failures. The system can train people. It cannot currently screen every point of entry, isolate every case in a facility equipped to contain it, or confirm every sample within the operational window.

When surveillance is the entire response, as it must be for a strain with no approved medical countermeasures, the standard is not whether the system exists on paper. It is whether it works at the border, at the hospital gate, and in the laboratory. On 3 October 2026, it did not work at the border. The patient passed through. He reached a hospital ward. He received visitors. He died on 5 October.

Kenya’s collaborative surveillance architecture for BVD is not fit for purpose. The plans are written, the personnel are trained, the preparedness scores are recorded. What is missing is the operational reliability to detect an imported case before it generates secondary transmission. Until that gap is closed, the next case will follow the same pathway as the first.